Skip to main content

Find Clinical Trials

Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

627 public trials 223 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

NCT07705334

Conditions: Adenoma, Advanced or Metastatic Solid Tumors, Breast Diseases, +40 more
Locations: SCRI at HCA HealthONE Denver, Colorado, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

HonorHealth Research Institute Scottsdale, Arizona, United States

View Trial Details

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations: City of Hope Duarte, California, United States

Hoag Memorial Hospital Presbyterian Irvine, California, United States

Biogenix Molecular, LLC Miami, Florida, United States

Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States

View all 14 locations

View Trial Details

Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667

Conditions: Adenocarcinoma, Alveolar Soft Part Sarcoma, Breast Diseases, +25 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

University Health Network Toronto, Ontario, Canada

The Research Institute of the McGill University Montreal, Quebec, Canada

View Trial Details

Recruiting

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

NCT06353997

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Ellison Institute of Technology (EITM) Los Angeles, California, United States

Providence Portland Cancer Institute - Franz Clinic Portland, Oregon, United States

Providence St. Vincent Medical Center Portland, Oregon, United States

View Trial Details

Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations: Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy

Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy

IRCCS Ospedale San Raffaele Milan, Segrate, Italy

View Trial Details

Recruiting

A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

NCT07513311

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

NCT07020806

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +10 more
Locations: University of California Davis Sacramento, California, United States

View Trial Details

Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions: Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

University of Miami Miami, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

View all 20 locations

View Trial Details

Recruiting

Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

NCT07652242

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: START Midwest Grand Rapids, Michigan, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

NCT07638852

Conditions: Brain Metastasases, Breast Diseases, Breast Neoplasms, +6 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details